Global AIDS fight ‘in danger’ but there is still time to get back on track, participants hear at AIDS 2022 conference. A few short weeks ago, CHAI marked the start of our 20th anniversary. We remembered the 2002 AIDS conference in Barcelona, which helped...
GARDP, Shionogi, and CHAI are working to accelerate access to cefiderocol, an antibiotic for serious Gram-negative bacterial infections, in low- and middle-income countries (LMICs). This RfP aims to solicit competitive bids for a contract to manufacture, obtain WHO...
Nigeria is ramping up the use of a test that can detect both HIV and syphilis simultaneously. But why is this test so vital to the health of mothers and their babies? A relatively high proportion of women are tested for HIV during pregnancy in many low-and...
August 1, 2022: Unitaid, The Aurum Institute, the Clinton Health Access Initiative (CHAI), and MedAccess today announced two new agreements to lower the price of rifapentine (RPT)-based treatments to prevent tuberculosis in low- and middle-income countries. The...
Approximately one in five people living with HIV are undiagnosed. As a gateway to treatment and prevention, HIV testing is critical across the cascade of care. But too often not accessible to those who need it. HIV self-tests can play an important role in closing the...
From the onset of the COVID-19 pandemic in March 2020, the Clinton Health Access Initiative (CHAI) has demonstrated commitment to increasing access to oxygen in response to the pandemic needs. Working alongside the Federal Ministry of Health (FMoH), CHAI, with funding...
CHAI is pleased to publish the Advanced HIV Disease (AHD) Impact Report, which provides a detailed look at progress made since 2019 to avert preventable deaths among people with AHD, best practices for AHD program implementation, and CHAI’s perspective of what more...
July 27, 2022: MedAccess, the Clinton Health Access Initiative (CHAI), and Wondfo today announced an agreement to make Wondfo’s HIV self-test available for US$1. The price is over 30 percent below the current lowest-priced World Health Organization (WHO) prequalified...
CHAI’s recently released Hepatitis C Market Memo is an update to the previous editions of Hepatitis market reports. It provides critical insights into the market and helps the public and private sectors develop better strategies to provide products and services to...
We are excited to publish the Hepatitis C Market Memo 2022, a brief covering the latest trends in the hepatitis C diagnostics and treatment markets since the publication of CHAI’s second HCV Market Intelligence Report in August 2021. This memo provides updates on key...
